Bioactive to immunoreactive ratio of circulating human chorionic gonadotropin as possible evaluation for the prognosis of threatened abortion

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 109, Issue 2, 2003, Pages 181-184

  Camejo, María I ^a,c   Proverbio, Fulgencio ^a   Febres, Freddy ^b   Casart, Ysabel C ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Maternidad Concepcion Palacios   (Venezuela)

^c UNIVERSIDAD SIMÓN BOLÍVAR   (Venezuela)

Author keywords

Bioactive immunoactive ratio; Human chorionic gonadotropin; Threatened abortion

Indexed keywords

CHORIONIC GONADOTROPIN; PROGESTERONE;

ABORTION; ARTICLE; BIOASSAY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOREACTIVITY; LEYDIG CELL; MEDICAL ASSESSMENT; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGNOSIS; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 0038353171     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00124-6     Document Type: Article

References (20)

1. Yuen B.H., Livingston J.E., Polan B.I., Wittman B.K., Sy L., Cannon W. Human chorionic gonadotropin, estradiol, progesterone, prolactin and β-scan ultrasound monitoring of complications in early pregnancy. Obst. Gynecol. 57:1981;207-214.
2. Al Sebai M.A., Diver M., Hipkin L.J. The role of single free beta human chorionic gonadotropin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Hum. Reprod. 11:1996;881-888.
3. Schmidt T., Rein D.T., Foth D., Eibach H., Kurbacher C.M., Mallmann P.et al. Pronostic value of repeated serum CA 125 measurements in first trimester pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 97:2001;168-173.
4. Merz W.E. The primate placenta and human chorionic. Exp. Clin. Endocrinol. 103:1994;222-234.
5. Braunstein G.D., Karow W.G., Gentrywc R.J., Wade M.E. First trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders. Am. J. Obst. Gynecol. 131:1978;25-32.
6. Jaakkola T., Ding Y.-Q., Kellokumpu-Lehtinen P., Valavaara R., Martikainn H., Tapanainen J.et al. The ratios of serum bioactive/immunoactive luteinizing hormone and follicle stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay. J. Clin. Endocrinol. Metab. 70:1990;1496-1505.
7. Robertson WR, Binden SP. The in vitro bioassay of peptide hormones. In: Hutton JC, Siddle K, editors. Peptide hormones a practical approach. Oxford: IRL Press; 1990.
8. Nagami M., Doherty M.G., Smith E.R., Chandrasekhar Y. Increased bioactive luteinizing hormone levels in post menopausal women with endometrial cancer. Am. J. Obst. Gynecol. 167:1992;1825-1830.
9. Mock P., Bischof P., Rivest R., Campana A., Chardonnens D. Modulation of human chorionic gonadotropin bioactivity during the first trimester of pregnancy. Hum. Reprod. 13:1998;2629-2632.
10. Casart Y., Camejo M.I., Proverbio F., Febres F. Bioactivity of serum hCG in preeclampsia. Obstet. Gynecol. 98:2001;463-465.
11. Diaz-Cueto L., Mendez J.P., Barrios de Tomasi J., Lee J.Y., Wide L., Veldhuis J.D.et al. Amplitude regulation of episodic release, in vitro biological to immunological ratio, and median charge of human chorionic gonadotropin in pregnancy. J. Endocrinol. Metab. 78:1994;890-897.
12. Cole L.A., Kardana A., Park S.-Y., Braunstein G.D. The deactivation of hCG by nicking and dissociation. J. Clin. Endocrinol. Metab. 76:1993;704-710.
13. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin. Chem. 43:1997;2233-2243.
14. Thotakura N.R., Weintraub B.D., Bahl O.P. The role of carbohydrate in human chorionic gonadotropin (HCG) action. Effects of N-linked carbohydrate chains from HCG and other glycoproteins on hormonal activity. Glycobiology. 5:1995;3-10.
15. Stanton P.G., Burgon P.G., Hearn M.T.W., Robertson D.M. Structural and functional characterization of hFSH and hLH isoforms. Mol. Cell Endocrinol. 125:1996;133-141.
16. Nemansky M., de Leeuw R., Wijnands R.A., van den Eijnden D.H. Enzymic remodelling of the N- and O-linked carbohydrate chains of human chorionic gonadotropin. Effects on biological activity and receptor binding. Eur. J. Biochem. 227:1995;880-888.
17. Dunkel L., Jia X.-C., Nishimori K., Boime I., Hsueh A.J.W. Deglicosylated human chorionic gonadotropin (hCG) antagonizes hCG Stimulation of 3′,5′-ciclic adenosine monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing hormone receptors. Endocrinology. 132:1993;763-769.
18. Kato K., Sairam M.R., Manjunath P. Inhibition of implantation and termination of pregnancy in the rat by a human chorionic gonadotropin antagonist. Endocrinology. 113:1983;195-199.
19. Quenby S., Farquharson R.G. Human chorionic gonadotropin supplementation in recurring pregnancy loss: a controlled trial. Fertil. Steril. 62:1994;708-710.
20. Toth P. Clinical data supporting the importance of vascular LH/hCG receptors of uterine blood vessels. Sem. Reprod. Med. 19:2001;55-61.